Estrella Immunopharma, Inc.
ESLACIK 0001844417 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone 0.0018
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Estrella Immunopharma, Inc.
| Name | Roles | Filings |
|---|---|---|
| Li Jianwei | OfficerDirector10% Owner | 2 |
| Xu Jiandong | Officer | 2 |
| Altman Jeffrey A | 10% Owner | 1 |
| Jiang Tao | - | 1 |
| Liu Cheng | OfficerDirector | 1 |
Showing 1-5 of 11
Page 1 of 3Next
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Estrella Immunopharma, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Xu Jiandong | 3 | 100% | +45.8% | +31.9% | +100.0% | +5.6% |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|